搜尋結果
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 1 日前As of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market ...
Indian shares log third straight month of gains on strong quarterly results
Reuters· 3 日前Indian shares logged their third straight month of gains on strong quarterly earnings by ...
Lagging Real Estate Stocks Have Dropped Too Far, Analysts Say
Bloomberg· 2 小時前Wall Street analysts see a double-digit upside potential for the S&P 500’s biggest losers this ...
Stocks making the biggest moves premarket: Apple, Amgen, Cloudflare and more
CNBC· 3 小時前Shares of the chocolate confectionary maker added about 1% after Hershey posted a first-quarter ...
Treasuries Extend Gains After Fed Less Hawkish Than Feared
Bloomberg· 2 日前Treasury yields fell, with the US two-year benchmark tumbling sharply below 5%, after Federal ...
Cramer says he's willing 'to pay up' for Viking, the biggest IPO of the year
CNBC· 17 小時前CNBC's Jim Cramer on Thursday reviewed the initial public offering of Viking, a cruise line ...
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
CNBC· 2 小時前Shares of Danish pharmaceutical giant Novo Nordisk slid 4% on Friday, extending a 2.7% loss on ...
Here's what to expect from the April jobs report on Friday
CNBC· 19 小時前Hiring likely continued at a brisk pace in April as investors look for any cracks in the labor ...
Yen clings to sharp gains after suspected intervention, Fed in focus
Reuters· 4 日前The yen held its line against the dollar on Tuesday after making sharp gains the previous day ...
Mastercard Stock Gained 20% In The Last 6 Months. Here’s What To Expect From Q1 Results
Forbes· 3 日前Mastercard (NYSE: MA) is scheduled to report its fiscal Q1 2024 results on Wednesday, May 1, ...